The solution is expected to be completed within the next 12 months and is anticipated to result in approximately a million dollars in revenues from software and services.

Mark Emkjer, president and CEO of Accelrys, said: "Our flexible integrated scientific business intelligence solution will better equip our customer to handle its complex high throughput catalysis and discovery business needs. Our technology has traditionally enabled our life-science customers to optimize the use of their scientific data. This agreement further validates our strategy to enable our customers in the oil and gas industry as well as other science-based industries to extract knowledge from their scientific data."

http://www.datamonitor.com

Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon

SES is a powerful client-server platform that streamlines the integration and analysis of the vast quantities of data flooding research informatics. SES provides an agile development environment, fast and secure deployment, minimal maintenance costs, and application extensibility. Utilizing SES, this customer will derive greater value from its information resources through enterprise-scale data flow control, extensive data mining capabilities, and effective reporting.

"Our flexible integrated scientific business intelligence solution will better equip our customer to handle its complex high throughput catalysis and discovery business needs," said Accelrys' President and Chief Executive Officer Mark J. Emkjer. "Our technology has traditionally enabled our life-science customers to optimize the use of their scientific data. This agreement further validates our strategy to enable our customers in the oil and gas industry as well as other science-based industries to extract knowledge from their scientific data."

About Accelrys, Inc.

Headquartered in San Diego, California, Accelrys develops scientific business intelligence software and solutions for the life sciences, energy, chemicals, aerospace, and consumer products industries. Our customers include many Fortune 500 companies and other commercial entities, as well as academic and government entities. We have a vast portfolio of computer-aided design modeling and simulation offerings which assist our customers in conducting scientific experiments 'in silico' in order to reduce the duration and cost of discovering and developing new drugs and materials. Our scientific business intelligence platform underlies most of our computer-aided design modeling and simulation offerings. Our platform can be used with our products, our competitors' products and our customers' proprietary predictive science products. Its flexibility, ease-of-use and advanced chemical, text and image analysis and reporting capabilities enable our customers to mine, aggregate, analyze and report scientific data from disparate sources, thereby better utilizing scientific data within their organizations. For more information about Accelrys, visit its website at http://accelrys.com/

Forward-Looking Statements

This press release contains forward-looking statements. Such statements, including statements relating to SES, the solution developed utilizing SES, its features, potential demand therefore, and other opportunities, both within the oil and gas market and otherwise, are subject to risks and uncertainties including, but not limited to, the risks that SES will not be successfully developed, that other opportunities will not materialize, that the expected revenue will not be derived from the solution, the oil and gas market and other markets, and other risks and uncertainties described in documents Accelrys has filed with the Securities and Exchange Commission, including its most recent report on Form 10-K and any subsequent interim filings. All forward-looking statements in this document are qualified entirely by the cautionary statements included in this document and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Accelrys disclaims any intent or obligation to publicly update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

SOURCE: Accelrys, Inc.

MKR Group 
Todd Kehrli or Charles Messman 
323-468-2300 
accl@mkr-group.com